title: [Therapy with beta-blockers in acute myocardial infarction in the aged].
abstract: Starting from the fact that during the first days the mortality is essentially determined by the degree of severity of the infarction and its complications, a particularly critical evaluation of the results is required. Patients with a bad prognosis usually have contra-indications for the application of beta-blockers during that phase. After the early complications have been overcome, the obtained findings are much easier to interpret in the sense of a therapeutical conception, and they have caused us to make the generalization--observing the contra-indications--to use beta-blockers in the framework of a complex therapy of myocardial infarction wherever it is possible. The results obtained require further verification, but justify, however, optimism on their part.
mesh_terms: D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use*; D000368:Aged; D002986:Clinical Trials as Topic; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D009203:Myocardial Infarction / Q000188:drug therapy*; D011412:Propanolamines / Q000627:therapeutic use*; D011433:Propranolol / Q000627:therapeutic use*
chemical_list: D000319:Adrenergic beta-Antagonists; D011412:Propanolamines; C011550:talinolol; D011433:Propranolol
vernacular_title: Therapie mit Betablockern bei akutem Herzinfarkt im Alter.